Tadashi Kasahara
Research Subjects
Research Interests
Tadashi Kasahara has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Yoshiko Sonoda
8 shared publicationsEriko Aizu-Yokota
Department of Biochemistry, Kyoritsu University of Pharmacy, 1-5-30, Shibakoen, Minato-ku, Tokyo 105-8512, Japan
6 shared publicationsK Hatake
6 shared publicationsK Matsushima
6 shared publicationsH Tomizuka
5 shared publicationsM Ikeda
5 shared publications
Latest Publications
- 1 February 2005
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 137 (2) , 189-197
Functional Role of c-Src in IL-1-Induced NF- B Activation: c-Src Is a Component of the IKK Complex
Interleukin-1 (IL-1) mediates numerous host responses through the rapid activation of nuclear factor-κB (NF-κB), but the signal pathways leading to NF-κB activation are regulated at multiple stages. Here, we propose a novel regulatory system for IL-1–induced NF-κB activation by a tyrosine kinase, c-Src. The kinase activity of c-Src increases in an IL-1–dependent manner and the ectopic expression of c-Src augments IL-1–induced NF-κB activation, suggesting the involvement of c-Src in IL-1 signaling. However, a Src family inhibitor, PP2 failed to inhibit IL-1–induced NF-κB activation, and the expression of a c-Src mutant lacking kinase activity (c-Src KD) augmented IL-1–induced NF-κB activation as well as wild type c-Src, indicating that the tyrosine kinase activity is not required for IL-1–induced NF-κB activation. Furthermore, a physiological interaction between c-Src and IκB kinase γ (IKKγ) was observed, implying the involvement of c-Src in the IKK-complex. While c-Src augmented IL-1–induced IKK activation independent of its kinase activity, the region comprising amino acids 361–440 in the c-Src kinase domain are required for NF-κB activation. The same region of c-Src is also required for IL-1–induced IKK activation and the association with IKKγ. Taken together, our results suggest that c-Src plays a critical role in IL-1–induced NF-κB activation through the IKK complex.
- 1 February 2005
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 137 (2) , 189-197
Functional Role of c-Src in IL-1-Induced NF- B Activation: c-Src Is a Component of the IKK Complex
Interleukin-1 (IL-1) mediates numerous host responses through the rapid activation of nuclear factor-κB (NF-κB), but the signal pathways leading to NF-κB activation are regulated at multiple stages. Here, we propose a novel regulatory system for IL-1–induced NF-κB activation by a tyrosine kinase, c-Src. The kinase activity of c-Src increases in an IL-1–dependent manner and the ectopic expression of c-Src augments IL-1–induced NF-κB activation, suggesting the involvement of c-Src in IL-1 signaling. However, a Src family inhibitor, PP2 failed to inhibit IL-1–induced NF-κB activation, and the expression of a c-Src mutant lacking kinase activity (c-Src KD) augmented IL-1–induced NF-κB activation as well as wild type c-Src, indicating that the tyrosine kinase activity is not required for IL-1–induced NF-κB activation. Furthermore, a physiological interaction between c-Src and IκB kinase γ (IKKγ) was observed, implying the involvement of c-Src in the IKK-complex. While c-Src augmented IL-1–induced IKK activation independent of its kinase activity, the region comprising amino acids 361–440 in the c-Src kinase domain are required for NF-κB activation. The same region of c-Src is also required for IL-1–induced IKK activation and the association with IKKγ. Taken together, our results suggest that c-Src plays a critical role in IL-1–induced NF-κB activation through the IKK complex.
- Open Access
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 27 (11) , 1735-1741
Proteome Analysis of Focal Adhesion Kinase (FAK)-Overexpressing Cells
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 27 (11) , 1735-1741
Open AccessProteome Analysis of Focal Adhesion Kinase (FAK)-Overexpressing Cells
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2004
- Published by Elsevier in International Immunopharmacology
- Vol. 4 (13) , 1633-1644
Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
- 1 January 2004
- Published by Elsevier in International Immunopharmacology
- Vol. 4 (13) , 1633-1644
Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line
- Open Access
- 1 January 2003
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 26 (8) , 1076-1081
Interleukin-10-Induced CCR5 Expression in Macrophage Like HL-60 Cells: Involvement of Erk1/2 and STAT-3
As an immunosuppressive and anti-inflammatory cytokine, IL-10 was recently reported to play roles in CCR5 expression in human monocytes. CCR5 promoter regions contain Oct-2, TCF-1α, GATA, and STAT binding sites. Here, we studied the signals involved in the CCR5 expression in IL-10-stimulated cells using the HL-60 cell line. HL-60 cells were stimulated with PMA and differentiated to macrophage-like cells, then stimulated with IL-10. IL-10 induced significant expression of CCR5 protein and CCR5 mRNA in these cells. The induction of CCR5 by IL-10 was inhibited by a MEK-1 inhibitor, PD98059. In addition, IL-10 induced tyrosine (Tyr) phosphorylation of Erk, as well as serine (Ser) and Tyr phosphorylation of STAT-3. Tyr phosphorylation of Erk and Ser phosphorylation of STAT-3 were inhibited by PD98059, while Tyr phosphorylation of STAT-3 was not inhibited by PD98059. DNA binding activity of STAT-3 was observed by the stimulation with IL-10, which was inhibited by PD98059. These results first indicate that Erk1/2 and STAT-3 regulate CCR5 expression, and that Erk-mediated phosphorylation of Ser is required for full stimulation of STAT-3 in CCR5 expression.
- 1 January 2003
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 26 (8) , 1076-1081
Open AccessInterleukin-10-Induced CCR5 Expression in Macrophage Like HL-60 Cells: Involvement of Erk1/2 and STAT-3
As an immunosuppressive and anti-inflammatory cytokine, IL-10 was recently reported to play roles in CCR5 expression in human monocytes. CCR5 promoter regions contain Oct-2, TCF-1α, GATA, and STAT binding sites. Here, we studied the signals involved in the CCR5 expression in IL-10-stimulated cells using the HL-60 cell line. HL-60 cells were stimulated with PMA and differentiated to macrophage-like cells, then stimulated with IL-10. IL-10 induced significant expression of CCR5 protein and CCR5 mRNA in these cells. The induction of CCR5 by IL-10 was inhibited by a MEK-1 inhibitor, PD98059. In addition, IL-10 induced tyrosine (Tyr) phosphorylation of Erk, as well as serine (Ser) and Tyr phosphorylation of STAT-3. Tyr phosphorylation of Erk and Ser phosphorylation of STAT-3 were inhibited by PD98059, while Tyr phosphorylation of STAT-3 was not inhibited by PD98059. DNA binding activity of STAT-3 was observed by the stimulation with IL-10, which was inhibited by PD98059. These results first indicate that Erk1/2 and STAT-3 regulate CCR5 expression, and that Erk-mediated phosphorylation of Ser is required for full stimulation of STAT-3 in CCR5 expression.
- 1 June 2002
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 4 (3) , 491-499
Antiapoptotic Action of Focal Adhesion Kinase (FAK) Against Ionizing Radiation
Focal adhesion kinase (FAK) has an antiapoptotic role in anchorage-dependent cells via an unknown mechanism. To elucidate the role of FAK in the antiapoptosis, we have demonstrated that FAK-overexpressed (HL-60/FAK) cells have marked resistance against various apoptotic stimuli. That is, HL-60/FAK cells were highly resistant to hydrogen peroxide or etoposide-induced apoptosis compared with the vector-transfected cells. In this study, we demonstrated that HL-60/FAK cells were highly resistant to ionizing radiation (IR)-induced apoptosis. IR at 10-40 Gy induced significant DNA fragmentation, activation of caspase-3 and -8, the processing of a proapoptotic BID, and mitochondrial release of cytochrome c in the parental or HL-60/Vect cells, whereas no significant DNA fragmentation or no other concurring events were observed in the HL-60/FAK cells. Of note is that, in the HL-60/FAK cells, phosphatidylinositol 3'-kinase-Akt survival pathway was activated, accompanied with significant induction of inhibitor-of-apoptosis proteins (cIAP-2, XIAP). Finally, constructs of FAK mutants revealed that the central kinase domain (K454), autophosphorylation site (Y397), as well as focal adhesion target regions (Y925), were prerequisite for the FAK function. These results indicated that mitochondria pathway is required for IR-induced apoptosis, and FAK overexpression prevents this pathway, thus rendering antiapoptotic states.
- 1 June 2002
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 4 (3) , 491-499
Antiapoptotic Action of Focal Adhesion Kinase (FAK) Against Ionizing Radiation
Focal adhesion kinase (FAK) has an antiapoptotic role in anchorage-dependent cells via an unknown mechanism. To elucidate the role of FAK in the antiapoptosis, we have demonstrated that FAK-overexpressed (HL-60/FAK) cells have marked resistance against various apoptotic stimuli. That is, HL-60/FAK cells were highly resistant to hydrogen peroxide or etoposide-induced apoptosis compared with the vector-transfected cells. In this study, we demonstrated that HL-60/FAK cells were highly resistant to ionizing radiation (IR)-induced apoptosis. IR at 10-40 Gy induced significant DNA fragmentation, activation of caspase-3 and -8, the processing of a proapoptotic BID, and mitochondrial release of cytochrome c in the parental or HL-60/Vect cells, whereas no significant DNA fragmentation or no other concurring events were observed in the HL-60/FAK cells. Of note is that, in the HL-60/FAK cells, phosphatidylinositol 3'-kinase-Akt survival pathway was activated, accompanied with significant induction of inhibitor-of-apoptosis proteins (cIAP-2, XIAP). Finally, constructs of FAK mutants revealed that the central kinase domain (K454), autophosphorylation site (Y397), as well as focal adhesion target regions (Y925), were prerequisite for the FAK function. These results indicated that mitochondria pathway is required for IR-induced apoptosis, and FAK overexpression prevents this pathway, thus rendering antiapoptotic states.
- 26 April 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (1) , 174-181
Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G
- 26 April 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 293 (1) , 174-181
Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G
- 1 November 2001
- Published by Elsevier in Trends in Immunology
- Vol. 22 (11) , 593-594
Macrophage signaling, apoptosis, lectins and leukocyte trafficking
- 1 November 2001
- Published by Elsevier in Trends in Immunology
- Vol. 22 (11) , 593-594
Macrophage signaling, apoptosis, lectins and leukocyte trafficking
- 1 June 2001
- Vol. 61 (11) , 4414-7
Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity: activation of caspase-3 and nuclear factor-kappaB.
We have reported previously that beta2-microglobulin (beta2m) induces apoptosis in leukemic cells in vitro, and that an interaction between beta2m and HLA class I antigen induces apoptosis. Here we examined whether beta2m can induce apoptosis in leukemic cells in vivo and whether it has an antitumor effect in tumor-bearing mice. Daily administration of 50 or 250 microg of beta2m induced apoptosis and an antitumor effect on K562 leukemia cell-bearing mice in the same manner as tumor necrosis factor-alpha. In tumor tissues in beta2m-treated mice, both caspase-3 and nuclear factor-kappaB (NF-kappaB) were stained more strongly than in control mice by anti-caspase-3 and anti-NF-kappaB p65/Rel A polyclonal antibodies. We also observed the in vivo immunological effects of beta2m on lymphoid and hematopoietic organs, such as thymus, bone marrow, Peyer's patches, liver, and spleen in normal mice. Using antibodies against caspase-3 and NF-kappaB, immunohistochemical staining showed that no specific tissues were damaged or stained in normal mice. We conclude that beta2m stimulates caspase-3 and NF-kappaB pathways to induce apoptosis, making it a useful approach to a new therapy for leukemia.
- 1 June 2001
- Vol. 61 (11) , 4414-7
Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity: activation of caspase-3 and nuclear factor-kappaB.
We have reported previously that beta2-microglobulin (beta2m) induces apoptosis in leukemic cells in vitro, and that an interaction between beta2m and HLA class I antigen induces apoptosis. Here we examined whether beta2m can induce apoptosis in leukemic cells in vivo and whether it has an antitumor effect in tumor-bearing mice. Daily administration of 50 or 250 microg of beta2m induced apoptosis and an antitumor effect on K562 leukemia cell-bearing mice in the same manner as tumor necrosis factor-alpha. In tumor tissues in beta2m-treated mice, both caspase-3 and nuclear factor-kappaB (NF-kappaB) were stained more strongly than in control mice by anti-caspase-3 and anti-NF-kappaB p65/Rel A polyclonal antibodies. We also observed the in vivo immunological effects of beta2m on lymphoid and hematopoietic organs, such as thymus, bone marrow, Peyer's patches, liver, and spleen in normal mice. Using antibodies against caspase-3 and NF-kappaB, immunohistochemical staining showed that no specific tissues were damaged or stained in normal mice. We conclude that beta2m stimulates caspase-3 and NF-kappaB pathways to induce apoptosis, making it a useful approach to a new therapy for leukemia.
- 1 February 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (2) , 282-288
FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells
- 1 February 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (2) , 282-288
FTY720, a Novel Immunosuppressive Agent, Induces Apoptosis in Human Glioma Cells